Search results for: 'rapid plastic packaging industry'

The packaging industry plays a major role in the pharmaceutical market. It not only provides containment and drug safety, but also ensures identity, convenience of handling, and delivery. It needs to balance complex considerations. Pharmaceutical packaging firms are some of the industry’s most innovative companies, as has been evident in the last 1...

The U.S. Rapid Microbiology Test Market report focuses on the changing platforms employed in clinical as well as non-clinical environments. This report covers the strep, STD, respiratory, gastrointestinal, and non-clinical applications. This report provides an in-depth analysis of the revenue and unit sales forecasts for the market, drivers and res...

An increasing focus on biologics, genomics, and multi-omics; the adoption of digital technologies; and a shift to patient-centric models are transforming the life sciences industry. At the same time, the emergence of value-based models, R&D activities to treat complex diseases, and healthcare consumerism provide an impetus to precision medicine. Wi...

05 Apr 2023  |  Asia Pacific  |  Market Outlook

Asia-Pacific Pharmaceutical Industry Outlook, 2023

Disruptive Technology Adoption and Outsourcing Growth is Advancing Innovation in the Pharmaceutical Industry

Infographics

×

Asia-Pacific’s pharmaceutical market is forecast to record 4.2% growth from 2022 to 2027, with China and Japan dominating the market in terms of value. Generics dominate the regional markets based on volume, directly impacting innovator molecule uptake. Nevertheless, Asia-Pacific is establishing itself as a global innovation hub, with China, Japan,...

This research service analyzes the market for rapid microbiology tests within the United States. The market was divided into the three segments. Each segment covers market trends, technology trends, competitive structure, market share analysis and revenue forecasts. The key challenges and strategies are covered for the total market overview.

This research analyzes how point-of-care (PoC) diagnostics is evolving from simple tests to decentralized, connected, and clinically actionable testing platforms across hospitals, outpatient settings, homes, and pharmacies.The study assesses key technology shifts, including rapid molecular testing, lateral flow assays, microfluidics, biosensors, sm...

The COVID-19 pandemic has not only revealed supply chain challenges in terms of meeting pandemic-induced demand but also showcased weaknesses with regard to facing disruptions on a global scale. Immediate impacts include supply volatility, steep price increases, and high levels of uncertainty. Despite the manufacturing reboot, supply chain inter...

In this analysis, Frost & Sullivan identifies and defines the leading trends shaping the global pharmaceutical landscape. The study period is 2022–2030, with 2024 as the base year and 2025–2028 as the forecast period. The geographic scope includes 5 regions: North America, Latin America (LATAM) and the Caribbean, Asia-Pacific (APAC), Europe, and th...

Research Scope: Economy, Industry Geographic Scope: Sri Lanka Industry Scope: Medical Tourism, Healthcare, Tourism Disparity in healthcare costs between developed and emerging countries, coupled with advanced healthcare infrastructure in emerging economies is helping to drive medical tourism in emerging countries. Sri Lanka is amongst the emergi...